検索結果 - David W. Vredevoogd

  • 検索結果 1 - 10 結果 / 10
結果の絞り込み
  1. 1
    TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors

    TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors 著者: Jennifer K. Wagner, David W. Vredevoogd, Xin Yu, Dong Lu, Daniel S. Peeper, Heike M. Hermanns, Jin Wang, Harald Wajant, Daniela Siegmund

    出版事項 2025
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool

    A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool 著者: Lianne Kok, Feline E. Dijkgraaf, Jos Urbanus, Kaspar Bresser, David W. Vredevoogd, Rebeca F. Cardoso, Leïla Perié, Joost B. Beltman, Ton N. Schumacher

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    In vitro-Induced Human IL-10+ B Cells Do Not Show a Subset-Defining Marker Signature and Plastically Co-express IL-10 With Pro-Inflammatory Cytokines

    In vitro-Induced Human IL-10+ B Cells Do Not Show a Subset-Defining Marker Signature and Plastically Co-express IL-10 With Pro-Inflammatory Cytokines 著者: Laura C. Lighaam, Peter‐Paul A. Unger, David W. Vredevoogd, Dorit Verhoeven, Ellen Vermeulen, Annelies W. Turksma, Anja ten Brinke, Theo Rispens, S. Marieke van Ham

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells

    RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells 著者: Zhengkui Zhang, Xiangjun Kong, Maarten A. Ligtenberg, Susan E. van Hal-van Veen, Nils L. Visser, Beaunelle de Bruijn, Kelly E. Stecker, Pim W. van der Helm, Thomas Kuilman, Esmée P. Hoefsmit, David W. Vredevoogd, Georgi Apriamashvili, Beau Baars, Emile E. Voest, Sjoerd Klarenbeek, Maarten Altelaar, Daniel S. Peeper

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade

    Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade 著者: Julia Boshuizen, Nora Pencheva, Oscar Krijgsman, Daniela D’Empaire Altimari, Patricia Garrido Castro, Beaunelle de Bruijn, Maarten A. Ligtenberg, Elke Gresnigt-Van den Heuvel, David W. Vredevoogd, Ji‐Ying Song, Nils L. Visser, Georgi Apriamashvili, Maarten L. Janmaat, Theo S. Plantinga, Patrick Franken, Mischa Houtkamp, Andreas Lingnau, Maria Jure‐Kunkel, Daniel S. Peeper

    出版事項 2021
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

    Reversal of pre-existing NGFR-driven tumor and immune therapy resistance 著者: Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman, Maarten A. Ligtenberg, Stéphanie A. Blankenstein, Beaunelle de Bruijn, Dennie T. Frederick, Juliana C.N. Kenski, Mara Parren, Marieke Brüggemann, Max F. Madu, Elisa A. Rozeman, Ji‐Ying Song, Hugo M. Horlings, Christian U. Blank, Alexander C.J. van Akkooi, Keith T. Flaherty, Genevieve M. Boland, Daniel S. Peeper

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling

    Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling 著者: Georgi Apriamashvili, David W. Vredevoogd, Oscar Krijgsman, Onno B. Bleijerveld, Maarten A. Ligtenberg, Beaunelle de Bruijn, Julia Boshuizen, Joleen J.H. Traets, Daniela D’Empaire Altimari, Alex van Vliet, Chun‐Pu Lin, Nils L. Visser, J.D. Londino, Rebekah Sanchez‐Hodge, Leah Oswalt, Selin Altınok, Jonathan C. Schisler, Maarten Altelaar, Daniel S. Peeper

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

    Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold 著者: David W. Vredevoogd, Thomas Kuilman, Maarten A. Ligtenberg, Julia Boshuizen, Kelly E. Stecker, Beaunelle de Bruijn, Oscar Krijgsman, Xinyao Huang, Juliana C.N. Kenski, Ruben Lacroix, Riccardo Mezzadra, Raquel Gomez-Eerland, Ufuk Yıldız, Ilknur Dagidir, Georgi Apriamashvili, Nordin D. Zandhuis, Vincent van der Noort, Nils L. Visser, Christian U. Blank, Maarten Altelaar, Ton N. Schumacher, Daniel S. Peeper

    出版事項 2019
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

    Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold 著者: David W. Vredevoogd, Thomas Kuilman, Maarten A. Ligtenberg, Julia Boshuizen, Kelly E. Stecker, Beaunelle de Bruijn, Oscar Krijgsman, Xinyao Huang, Juliana C.N. Kenski, Ruben Lacroix, Riccardo Mezzadra, Raquel Gomez-Eerland, Ufuk Yıldız, Ilknur Dagidir, Georgi Apriamashvili, Nordin D. Zandhuis, Vincent van der Noort, Nils L. Visser, Christian U. Blank, Maarten Altelaar, Ton N. Schumacher, Daniel S. Peeper

    出版事項 2020
    全文の入手
    Errata/Corrigenda
    お気に入りに追加
    保存先:
  10. 10
    An adverse tumor-protective effect of IDO1 inhibition

    An adverse tumor-protective effect of IDO1 inhibition 著者: Juliana C.N. Kenski, Xinyao Huang, David W. Vredevoogd, Beaunelle de Bruijn, Joleen J.H. Traets, Sofía Ibáñez-Molero, Sebastiaan M. Schieven, Alex van Vliet, Oscar Krijgsman, Thomas Kuilman, Joanna Poźniak, Fabricio Loayza‐Puch, Alexandra M. Terry, Judith M. Müller, Meike E. W. Logtenberg, Marjolein de Bruijn, Pierre Lévy, Pierre-René Körner, Colin R. Goding, Ton N. Schumacher, Jean‐Christophe Marine, Reuven Agami, Daniel S. Peeper

    出版事項 2023
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: